Electromed Inc. has released an investor presentation highlighting its recent financial and operational performance. The company reported last twelve months net revenues of $68.9 million and a market capitalization of $241.1 million, with no debt and $13.8 million in cash as of December 31, 2025. Electromed emphasized its position in the airway clearance market, particularly through its SmartVest® Airway Clearance System, which utilizes High Frequency Chest Wall Oscillation (HFCWO) technology. The presentation noted clinical data supporting the effectiveness of SmartVest®, including reductions in hospitalizations and antibiotic prescriptions for bronchiectasis patients. The company also detailed its direct-to-patient and provider model, strong reimbursement coverage, and focus on patient outcomes tracking through tools like SmartNotes™ and telerespiratory services. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electromed Inc. published the original content used to generate this news brief on February 10, 2026, and is solely responsible for the information contained therein.